{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:43:55Z","timestamp":1791895435876,"version":"4.3.4"},"reference-count":117,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,12,30]],"date-time":"2008-12-30T00:00:00Z","timestamp":1230595200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cell Res"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1038\/cr.2008.326","type":"journal-article","created":{"date-parts":[[2008,12,30]],"date-time":"2008-12-30T07:20:50Z","timestamp":1230621650000},"page":"116-127","source":"Crossref","is-referenced-by-count":566,"title":["TGF-\u03b2 signaling in vascular biology and dysfunction"],"prefix":"10.1038","volume":"19","author":[{"given":"Marie-Jos\u00e9","family":"Goumans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"ten Dijke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,12,30]]},"reference":[{"key":"BFcr2008326_CR1","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/37284","volume":"390","author":"C-H Heldin","year":"1997","unstructured":"Heldin C-H, Miyazono K, ten Dijke P . TGF-\u03b2 signalling from cell membrane to nucleus through SMAD proteins. Nature 1997; 390:465\u2013471.","journal-title":"Nature"},{"key":"BFcr2008326_CR2","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S0092-8674(03)00432-X","volume":"113","author":"Y Shi","year":"2003","unstructured":"Shi Y, Massagu\u00e9 J . Mechanisms of TGF-\u03b2 signaling from cell membrane to the nucleus. Cell 2003; 113:685\u2013700.","journal-title":"Cell"},{"key":"BFcr2008326_CR3","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1038\/nrm2297","volume":"8","author":"B Schmierer","year":"2007","unstructured":"Schmierer B, Hill CS . TGF\u03b2-SMAD signal transduction: molecular specificity and functional flexibility. Nat Rev Mol Cell Biol 2007; 8:970\u2013982.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BFcr2008326_CR4","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/nrm2262","volume":"8","author":"P ten Dijke","year":"2007","unstructured":"ten Dijke P, Arthur HM . Extracellular control of TGF\u03b2 signalling in vascular development and disease. Nat Rev Mol Cell Biol 2007; 8:857\u2013869.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BFcr2008326_CR5","doi-asserted-by":"publisher","first-page":"2626","DOI":"10.1073\/pnas.97.6.2626","volume":"97","author":"SP Oh","year":"2000","unstructured":"Oh SP, Seki T, Goss KA, et al. Activin receptor-like kinase 1 modulates transforming growth factor-\u03b21 signaling in the regulation of angiogenesis. Proc Natl Acad Sci USA 2000; 97:2626\u20132631.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcr2008326_CR6","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1093\/emboj\/21.7.1743","volume":"21","author":"MJ Goumans","year":"2002","unstructured":"Goumans MJ, Valdimarsdottir G, Itoh S, Rosendahl A, Sideras P, ten Dijke P . Balancing the activation state of the endothelium via two distinct TGF-\u03b2 type I receptors. EMBO J 2002; 21:1743\u20131753.","journal-title":"EMBO J"},{"key":"BFcr2008326_CR7","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s10456-008-9101-9","volume":"11","author":"P ten Dijke","year":"2008","unstructured":"ten Dijke P, Goumans MJ, Pardali E . Endoglin in angiogenesis and vascular diseases. Angiogenesis 2008; 11:79\u201389.","journal-title":"Angiogenesis"},{"key":"BFcr2008326_CR8","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1016\/0092-8674(93)90368-Z","volume":"73","author":"F L\u00f3pez-Casillas","year":"1993","unstructured":"L\u00f3pez-Casillas F, Wrana JL, Massagu\u00e9 J . Betaglycan presents ligand to the TGF\u03b2 signaling receptor. Cell 1993; 73:1435\u20131444.","journal-title":"Cell"},{"key":"BFcr2008326_CR9","doi-asserted-by":"publisher","first-page":"22765","DOI":"10.1074\/jbc.M401350200","volume":"279","author":"E Del Re","year":"2004","unstructured":"Del Re E, Babitt JL, Pirani A, Schneyer AL, Lin HY . In the absence of type III receptor, the transforming growth factor (TGF)-\u03b2 type II-B receptor requires the type I receptor to bind TGF-\u03b22. J Biol Chem 2004; 279:22765\u20132272.","journal-title":"J Biol Chem"},{"key":"BFcr2008326_CR10","doi-asserted-by":"publisher","first-page":"13567","DOI":"10.1074\/jbc.270.22.13567","volume":"270","author":"S Sankar","year":"1995","unstructured":"Sankar S, Mahooti-Brooks N, Centrella M, McCarthy TL, Madri JA . Expression of transforming growth factor type III receptor in vascular endothelial cells increases their responsiveness to transforming growth factor \u03b22. J Biol Chem 1995; 270:13567\u201313572.","journal-title":"J Biol Chem"},{"key":"BFcr2008326_CR11","doi-asserted-by":"crossref","first-page":"19027","DOI":"10.1016\/S0021-9258(18)41732-2","volume":"267","author":"S Cheifetz","year":"1992","unstructured":"Cheifetz S, Bell\u00f3n T, Cal\u00e9s C, et al. Endoglin is a component of the transforming growth factor-\u03b2 receptor system in human endothelial cells. J Biol Chem 1992; 267:19027\u201319030.","journal-title":"J Biol Chem"},{"key":"BFcr2008326_CR12","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1083\/jcb.133.5.1109","volume":"133","author":"P Lastres","year":"1996","unstructured":"Lastres P, Letamend\u00eda A, Zhang H, et al. Endoglin modulates cellular responses to TGF-\u03b21. J Cell Biol 1996; 133:1109\u20131121.","journal-title":"J Cell Biol"},{"key":"BFcr2008326_CR13","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1242\/jcs.002949","volume":"120","author":"M Scharpfenecker","year":"2007","unstructured":"Scharpfenecker M, van Dinther M, Liu Z, et al. BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis. J Cell Sci 2007; 120:964\u2013972.","journal-title":"J Cell Sci"},{"key":"BFcr2008326_CR14","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1182\/blood-2006-07-034124","volume":"109","author":"L David","year":"2007","unstructured":"David L, Mallet C, Mazerbourg S, Feige JJ, Bailly S . Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells. Blood 2007; 109:1953\u20131961.","journal-title":"Blood"},{"key":"BFcr2008326_CR15","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1161\/CIRCRESAHA.107.165530","volume":"102","author":"L David","year":"2008","unstructured":"David L, Mallet C, Keramidas M, et al. Bone morphogenetic protein-9 is a circulating vascular quiescence factor. Circ Res 2008; 102:914\u2013922.","journal-title":"Circ Res"},{"key":"BFcr2008326_CR16","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/nrm2183","volume":"8","author":"RH Adams","year":"2007","unstructured":"Adams RH, Alitalo K . Molecular regulation of angiogenesis and lymphangiogenesis. Nat Rev Mol Cell Biol 2007; 8:464\u2013478.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BFcr2008326_CR17","doi-asserted-by":"publisher","first-page":"5692","DOI":"10.1021\/bi00294a002","volume":"22","author":"AB Roberts","year":"1983","unstructured":"Roberts AB, Anzano MA, Meyers CA, et al. Purification and properties of a type beta transforming growth factor from bovine kidney. Biochemistry 1983; 22:5692\u20135698.","journal-title":"Biochemistry"},{"key":"BFcr2008326_CR18","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/386671a0","volume":"386","author":"W Risau","year":"1997","unstructured":"Risau W . Mechanisms of angiogenesis. Nature 1997; 386:671\u2013674.","journal-title":"Nature"},{"key":"BFcr2008326_CR19","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/S0092-8674(00)81810-3","volume":"87","author":"J Folkman","year":"1996","unstructured":"Folkman J, D'Amore PA . Blood vessel formation: what is its molecular basis? Cell 1996; 87:1153\u20131155.","journal-title":"Cell"},{"key":"BFcr2008326_CR20","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1038\/nature04478","volume":"438","author":"P Carmeliet","year":"2005","unstructured":"Carmeliet P . Angiogenesis in life, disease and medicine. Nature 2005; 438:932\u2013936.","journal-title":"Nature"},{"key":"BFcr2008326_CR21","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s10157-006-0448-1","volume":"11","author":"M Eguchi","year":"2007","unstructured":"Eguchi M, Masuda H, Asahara T . Endothelial progenitor cells for postnatal vasculogenesis. Clin Exp Nephrol 2007; 11:18\u201325.","journal-title":"Clin Exp Nephrol"},{"key":"BFcr2008326_CR22","first-page":"253","volume":"44","author":"MJ Goumans","year":"2000","unstructured":"Goumans MJ, Mummery C . Functional analysis of the TGF\u03b2 receptor\/Smad pathway through gene ablation in mice. Int J Dev Biol 2000; 44:253\u2013265.","journal-title":"Int J Dev Biol"},{"key":"BFcr2008326_CR23","doi-asserted-by":"publisher","first-page":"4269","DOI":"10.1242\/jcs.013169","volume":"120","author":"RL Carvalho","year":"2007","unstructured":"Carvalho RL, Itoh F, Goumans MJ, et al. Compensatory signalling induced in the yolk sac vasculature by deletion of TGF\u03b2 receptors in mice. J Cell Sci 2007; 120:4269\u20134277.","journal-title":"J Cell Sci"},{"key":"BFcr2008326_CR24","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1006\/dbio.2001.0469","volume":"240","author":"RJ Lechleider","year":"2001","unstructured":"Lechleider RJ, Ryan JL, Garrett L, et al. Targeted mutagenesis of Smad1 reveals an essential role in chorioallantoic fusion. Dev Biol 2001; 240:157\u2013167.","journal-title":"Dev Biol"},{"key":"BFcr2008326_CR25","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1242\/dev.128.18.3609","volume":"128","author":"KD Tremblay","year":"2001","unstructured":"Tremblay KD, Dunn NR, Robertson EJ . Mouse embryos lacking Smad1 signals display defects in extra-embryonic tissues and germ cell formation. Development 2001; 128:3609\u20133621.","journal-title":"Development"},{"key":"BFcr2008326_CR26","doi-asserted-by":"publisher","first-page":"7683","DOI":"10.1128\/MCB.00577-07","volume":"27","author":"Y Lan","year":"2007","unstructured":"Lan Y, Liu B, Yao H, et al. Essential role of endothelial Smad4 in vascular remodeling and integrity. Mol Cell Biol 2007; 27:7683\u20137692.","journal-title":"Mol Cell Biol"},{"key":"BFcr2008326_CR27","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1006\/dbio.1999.9594","volume":"219","author":"H Chang","year":"2000","unstructured":"Chang H, Zwijsen A, Vogel H, Huylebroeck D, Matzuk MM . Smad5 is essential for left-right asymmetry in mice. Dev Biol 2000; 219:71\u201378.","journal-title":"Dev Biol"},{"key":"BFcr2008326_CR28","doi-asserted-by":"publisher","first-page":"9314","DOI":"10.1073\/pnas.94.17.9314","volume":"94","author":"JN Topper","year":"1997","unstructured":"Topper JN, Cai J, Qiu Y, et al. Vascular MADs: two novel MAD-related genes selectively inducible by flow in human vascular endothelium. Proc Natl Acad Sci USA 1997; 94:9314\u20139319.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcr2008326_CR29","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/(SICI)1097-0177(199902)214:2<141::AID-AJA4>3.0.CO;2-S","volume":"214","author":"A Zwijsen","year":"1999","unstructured":"Zwijsen A, Goumans MJ, Lawson KA, Van Rooijen MA, Mummery CL . Ectopic expression of the transforming growth factor beta type II receptor disrupts mesoderm organisation during mouse gastrulation. Dev Dyn 1999; 214:141\u2013151.","journal-title":"Dev Dyn"},{"key":"BFcr2008326_CR30","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/72835","volume":"24","author":"KM Galvin","year":"2000","unstructured":"Galvin KM, Donovan MJ, Lynch CA, et al. A role for smad6 in development and homeostasis of the cardiovascular system. Nat Genet 2000; 24:171\u2013174.","journal-title":"Nat Genet"},{"key":"BFcr2008326_CR31","doi-asserted-by":"publisher","unstructured":"Chen Q, Chen H, Zheng D, et al. Smad7 is required for the development and function of heart. J Biol Chem 2008 Oct 24. doi: 10.1074\/jbc.M807233200 .","DOI":"10.1074\/jbc.M807233200"},{"key":"BFcr2008326_CR32","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1002\/(SICI)1097-0177(199708)209:4<418::AID-AJA9>3.0.CO;2-L","volume":"4","author":"BA Roelen","year":"1997","unstructured":"Roelen BA, van Rooijen MA, Mummery CL . Expression of ALK-1, a type 1 serine\/threonine kinase receptor, coincides with sites of vasculogenesis and angiogenesis in early mouse development. Dev Dyn 1997; 4:418\u2013430.","journal-title":"Dev Dyn"},{"key":"BFcr2008326_CR33","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/S1097-2765(03)00386-1","volume":"12","author":"MJ Goumans","year":"2003","unstructured":"Goumans MJ, Valdimarsdottir G, Itoh S, et al. Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGF\u03b2\/ALK5 signaling. Mol Cell 2003; 12:817\u2013828.","journal-title":"Mol Cell"},{"key":"BFcr2008326_CR34","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1083\/jcb.134.6.1563","volume":"134","author":"G Deng","year":"1996","unstructured":"Deng G, Curriden SA, Wang S, Rosenberg S, Loskutoff DJ . Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptor-mediated cell adhesion and release? J Cell Biol. 1996; 134:1563\u20131571.","journal-title":"J Cell Biol"},{"key":"BFcr2008326_CR35","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1083\/jcb.200305147","volume":"163","author":"T Watabe","year":"2003","unstructured":"Watabe T, Nishihara A, Mishima K, et al. TGF-\u03b2 receptor kinase inhibitor enhances growth and integrity of embryonic stem cell-derived endothelial cells. J Cell Biol 2003; 163:1303\u20131311.","journal-title":"J Cell Biol"},{"key":"BFcr2008326_CR36","doi-asserted-by":"publisher","first-page":"4031","DOI":"10.1016\/j.febslet.2005.06.018","volume":"579","author":"AA Birukova","year":"2005","unstructured":"Birukova AA, Adyshev D, Gorshkov B, Birukov KG, Verin AD . ALK5 and Smad4 are involved in TGF-\u03b21-induced pulmonary endothelial permeability. FEBS Lett 2005; 579:4031\u20134037.","journal-title":"FEBS Lett"},{"key":"BFcr2008326_CR37","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1038\/emboj.2008.46","volume":"27","author":"N Rudini","year":"2008","unstructured":"Rudini N, Felici A, Giampietro C, et al.VE-cadherin is a critical endothelial regulator of TGF-\u03b2 signalling. EMBO J 2008; 27:993\u20131004.","journal-title":"EMBO J"},{"key":"BFcr2008326_CR38","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1093\/cvr\/cvm097","volume":"77","author":"JF Santibanez","year":"2008","unstructured":"Santibanez JF, Blanco FJ, Garrido-Martin EM, Sanz-Rodriguez F, del Pozo MA, Bernabeu C . Caveolin-1 interacts and cooperates with the transforming growth factor-\u03b2 type I receptor ALK1 in endothelial caveolae. Cardiovasc Res 2008; 77:791\u2013799.","journal-title":"Cardiovasc Res"},{"key":"BFcr2008326_CR39","doi-asserted-by":"publisher","first-page":"4495","DOI":"10.1182\/blood.V100.13.4495","volume":"100","author":"S Lamouille","year":"2002","unstructured":"Lamouille S, Mallet C, Feige JJ, Bailly S . Activin receptor-like kinase 1 is implicated in the maturation phase of angiogenesis. Blood 2002; 100:4495\u20134501.","journal-title":"Blood"},{"key":"BFcr2008326_CR40","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1634\/stemcells.2005-0494","volume":"24","author":"C Mallet","year":"2006","unstructured":"Mallet C, Vittet D, Feige JJ, Bailly S . TGF\u03b21 induces vasculogenesis and inhibits angiogenic sprouting in an embryonic stem cell differentiation model: respective contribution of ALK1 and ALK5. Stem Cells 2006; 24:2420\u20132427.","journal-title":"Stem Cells"},{"key":"BFcr2008326_CR41","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1161\/01.CIR.0000033830.36431.46","volume":"106","author":"G Valdimarsdottir","year":"2002","unstructured":"Valdimarsdottir G, Goumans MJ, Rosendahl A, et al. Stimulation of Id1 expression by bone morphogenetic protein is sufficient and necessary for bone morphogenetic protein-induced activation of endothelial cells. Circulation 2002; 106:2263\u20132270.","journal-title":"Circulation"},{"key":"BFcr2008326_CR42","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1093\/jb\/mvm215","volume":"143","author":"Y Suzuki","year":"2008","unstructured":"Suzuki Y, Montagne K, Nishihara A, Watabe T, Miyazono K . BMPs promote proliferation and migration of endothelial cells via stimulation of VEGF-A\/VEGFR2 and angiopoietin-1\/Tie2 signalling. J Biochem 2008; 143:199\u2013206.","journal-title":"J Biochem"},{"key":"BFcr2008326_CR43","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1158\/1541-7786.141.2.3","volume":"2","author":"EM Langenfeld","year":"2004","unstructured":"Langenfeld EM, Langenfeld J . Bone morphogenetic protein-2 stimulates angiogenesis in developing tumors. Mol Cancer Res 2004; 2:141\u2013149.","journal-title":"Mol Cancer Res"},{"key":"BFcr2008326_CR44","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1161\/CIRCRESAHA.108.178434","volume":"103","author":"J Heinke","year":"2008","unstructured":"Heinke J, Wehofsits L, Zhou Q, et al. BMPER is an endothelial cell regulator and controls bone morphogenetic protein-4-dependent angiogenesis. Circ Res 2008; 103:804\u2013812.","journal-title":"Circ Res"},{"key":"BFcr2008326_CR45","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1161\/01.RES.0000200180.01710.e6","volume":"98","author":"K Teichert-Kuliszewska","year":"2006","unstructured":"Teichert-Kuliszewska K, Kutryk MJ, Kuliszewski MA, et al. Bone morphogenetic protein receptor-2 signaling promotes pulmonary arterial endothelial cell survival: implications for loss-of-function mutations in the pathogenesis of pulmonary hypertension. Circ Res 2006; 98:209\u2013217.","journal-title":"Circ Res"},{"key":"BFcr2008326_CR46","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1203\/pdr.0b013e3180332cba","volume":"61","author":"K Takahashi","year":"2007","unstructured":"Takahashi K, Kogaki S, Matsushita T, Nasuno S, Kurotobi S, Ozono K . Hypoxia induces alteration of bone morphogenetic protein receptor signaling in pulmonary artery endothelial cell. Pediatr Res 2007; 61:392\u2013397.","journal-title":"Pediatr Res"},{"key":"BFcr2008326_CR47","doi-asserted-by":"crossref","first-page":"20533","DOI":"10.1016\/S0021-9258(17)30535-5","volume":"265","author":"S Cheifetz","year":"1990","unstructured":"Cheifetz S, Hernandez H, Laiho M, ten Dijke P, Iwata KK, Massagu\u00e9 J . Distinct transforming growth factor-\u03b2 (TGF-\u03b2) receptor subsets as determinants of cellular responsiveness to three TGF-\u03b2 isoforms. J Biol Chem 1990; 265:20533\u201320538.","journal-title":"J Biol Chem"},{"key":"BFcr2008326_CR48","doi-asserted-by":"publisher","first-page":"5550","DOI":"10.1046\/j.1432-1327.2000.01621.x","volume":"267","author":"SH Wong","year":"2000","unstructured":"Wong SH, Hamel L, Chevalier S, Philip A . Endoglin expression on human microvascular endothelial cells association with betaglycan and formation of higher order complexes with TGF-\u03b2 signalling receptors. Eur J Biochem 2000; 267:5550\u20135560.","journal-title":"Eur J Biochem"},{"key":"BFcr2008326_CR49","doi-asserted-by":"publisher","first-page":"4018","DOI":"10.1038\/sj.emboj.7600386","volume":"23","author":"F Lebrin","year":"2004","unstructured":"Lebrin F, Goumans MJ, Jonker L, et al. Endoglin promotes endothelial cell proliferation and TGF-\u03b2\/ALK1 signal transduction. EMBO J 2004; 23:4018\u20134028.","journal-title":"EMBO J"},{"key":"BFcr2008326_CR50","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1159\/000080340","volume":"14","author":"J Obreo","year":"2004","unstructured":"Obreo J, D\u00edez-Marques L, Lamas S, et al. Endoglin expression regulates basal and TGF-\u03b21-induced extracellular matrix synthesis in cultured L6E9 myoblasts. Cell Physiol Biochem 2004; 14:301\u2013310.","journal-title":"Cell Physiol Biochem"},{"key":"BFcr2008326_CR51","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1002\/jcp.20311","volume":"204","author":"FJ Blanco","year":"2005","unstructured":"Blanco FJ, Santibanez JF, Guerrero-Esteo M, Langa C, Vary CP, Bernabeu C . Interaction and functional interplay between endoglin and ALK-1, two components of the endothelial transforming growth factor-\u03b2 receptor complex. J Cell Physiol 2005; 204:574\u2013584.","journal-title":"J Cell Physiol"},{"key":"BFcr2008326_CR52","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.cardiores.2005.11.020","volume":"69","author":"M Jerkic","year":"2006","unstructured":"Jerkic M, Rodr\u00edguez-Barbero A, Prieto M, et al. Reduced angiogenic responses in adult Endoglin heterozygous mice. Cardiovasc Res 2006; 69:845\u2013854.","journal-title":"Cardiovasc Res"},{"key":"BFcr2008326_CR53","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1242\/jcs.00470","volume":"116","author":"C Li","year":"2003","unstructured":"Li C, Issa R, Kumar P, et al. CD105 prevents apoptosis in hypoxic endothelial cells. J Cell Sci 2003; 116:2677\u20132685.","journal-title":"J Cell Sci"},{"key":"BFcr2008326_CR54","doi-asserted-by":"publisher","first-page":"32527","DOI":"10.1074\/jbc.M803059200","volume":"283","author":"NY Lee","year":"2008","unstructured":"Lee NY, Ray BN, How T, Blobe GC . Endoglin promotes transforming growth factor-\u03b2-mediated smad 1\/5\/8 signaling and inhibits endothelial cell migration through its association with GIPC. J Biol Chem 2008; 283: 32527\u201332533.","journal-title":"J Biol Chem"},{"key":"BFcr2008326_CR55","doi-asserted-by":"publisher","first-page":"6557","DOI":"10.1038\/sj.onc.1206813","volume":"22","author":"E Fonsatti","year":"2003","unstructured":"Fonsatti E, Altomonte M, Nicotra MR, Natali PG, Maio M . Endoglin (CD105): a powerful therapeutic target on tumor-associated angiogenetic blood vessels. Oncogene 2003; 22:6557\u20136563.","journal-title":"Oncogene"},{"key":"BFcr2008326_CR56","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1096\/fj.02-0634rev","volume":"17","author":"SE Duff","year":"2003","unstructured":"Duff SE, Li C, Garland JM, Kumar S . CD105 is important for angiogenesis: evidence and potential applications. FASEB J 2003; 17:984\u2013992.","journal-title":"FASEB J"},{"key":"BFcr2008326_CR57","doi-asserted-by":"publisher","first-page":"4450","DOI":"10.1038\/sj.onc.1208644","volume":"24","author":"E P\u00e9rez-G\u00f3mez","year":"2005","unstructured":"P\u00e9rez-G\u00f3mez E, Eleno N, L\u00f3pez-Novoa JM, et al. Characterization of murine S-endoglin isoform and its effects on tumor development. Oncogene 2005; 24:4450\u20134461.","journal-title":"Oncogene"},{"key":"BFcr2008326_CR58","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1242\/jcs.023283","volume":"121","author":"S Velasco","year":"2008","unstructured":"Velasco S, Alvarez-Mu\u00f1oz P, Pericacho M, et al. L- and S-endoglin differentially modulate TGF\u03b21 signaling mediated by ALK1 and ALK5 in L6E9 myoblasts. J Cell Sci 2008; 121:913\u2013919.","journal-title":"J Cell Sci"},{"key":"BFcr2008326_CR59","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1161\/CIRCRESAHA.108.176552","volume":"103","author":"FJ Blanco","year":"2008","unstructured":"Blanco FJ, Grande MT, Langa C, et al. S-Endoglin expression is induced in senescent endothelial cells and contributes to vascular pathology. Circ Res 2008; 103:1383\u20131392.","journal-title":"Circ Res"},{"key":"BFcr2008326_CR60","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1161\/01.ATV.0000225287.20034.2c","volume":"26","author":"A Bobik","year":"2006","unstructured":"Bobik A . Transforming growth factor-\u03b2s and vascular disorders. Arterioscler Thromb Vasc Biol 2006; 26:1712\u20131720.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BFcr2008326_CR61","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1152\/physrev.1995.75.3.487","volume":"75","author":"GK Owens","year":"1995","unstructured":"Owens GK . Regulation of differentiation of vascular smooth muscle cells. Physiol Rev 1995; 75:487\u2013517.","journal-title":"Physiol Rev"},{"key":"BFcr2008326_CR62","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1161\/01.RES.0000190604.90049.71","volume":"97","author":"P Qiu","year":"2005","unstructured":"Qiu P, Ritchie RP, Fu Z, et al. Myocardin enhances Smad3-mediated transforming growth factor-\u03b21 signaling in a CArG box-independent manner: Smad-binding element is an important cis element for SM22a transcription in vivo. Circ Res 2005; 97:983\u2013991.","journal-title":"Circ Res"},{"key":"BFcr2008326_CR63","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.devcel.2006.05.011","volume":"11","author":"G Nishimura","year":"2006","unstructured":"Nishimura G, Manabe I, Tsushima K, et al. DeltaEF1 mediates TGF-\u03b2 signaling in vascular smooth muscle cell differentiation. Dev Cell 2006; 11:93\u2013104.","journal-title":"Dev Cell"},{"key":"BFcr2008326_CR64","doi-asserted-by":"publisher","first-page":"16388","DOI":"10.1074\/jbc.M309664200","volume":"279","author":"MW Feinberg","year":"2004","unstructured":"Feinberg MW, Watanabe M, Lebedeva MA, et al. Transforming growth factor-\u03b21 inhibition of vascular smooth muscle cell activation is mediated via Smad3. J Biol Chem 2004; 279:16388\u201316393.","journal-title":"J Biol Chem"},{"key":"BFcr2008326_CR65","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1161\/01.RES.0000194331.76925.5c","volume":"97","author":"J Wei","year":"2005","unstructured":"Wei J, Gorman TE, Liu X, et al. Increased neointima formation in cysteine-rich protein 2-deficient mice in response to vascular injury. Circ Res 2005; 97:1323\u20131331.","journal-title":"Circ Res"},{"key":"BFcr2008326_CR66","doi-asserted-by":"publisher","first-page":"15003","DOI":"10.1074\/jbc.M801621200","volume":"283","author":"DW Lin","year":"2008","unstructured":"Lin DW, Chang IC, Tseng A, et al. Transforming growth factor \u03b2 up-regulates cysteine-rich protein 2 in vascular smooth muscle cells via activating transcription factor 2. J Biol Chem 2008; 283:15003\u201315014.","journal-title":"J Biol Chem"},{"key":"BFcr2008326_CR67","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1161\/01.RES.0000163980.55495.44","volume":"96","author":"K Kobayashi","year":"2005","unstructured":"Kobayashi K, Yokote K, Fujimoto M, et al. Targeted disruption of TGF-\u03b2-Smad3 signaling leads to enhanced neointimal hyperplasia with diminished matrix deposition in response to vascular injury. Circ Res 2005; 96:904\u2013912.","journal-title":"Circ Res"},{"key":"BFcr2008326_CR68","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.ydbio.2007.06.009","volume":"308","author":"ML Mancini","year":"2007","unstructured":"Mancini ML, Verdi JM, Conley BA, et al. Endoglin is required for myogenic differentiation potential of neural crest stem cells. Dev Biol 2007; 308: 520\u2013533.","journal-title":"Dev Biol"},{"key":"BFcr2008326_CR69","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1159\/000025634","volume":"36","author":"RN Willette","year":"1999","unstructured":"Willette RN, Gu JL, Lysko PG, Anderson KM, Minehart H, Yue T . BMP-2 gene expression and effects on human vascular smooth muscle cells. J Vasc Res 1999; 36:120\u2013125.","journal-title":"J Vasc Res"},{"key":"BFcr2008326_CR70","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1172\/JCI32503","volume":"118","author":"G Hansmann","year":"2008","unstructured":"Hansmann G, de Jesus Perez VA, Alastalo TP, et al. An antiproliferative BMP-2\/PPARgamma\/apoE axis in human and murine SMCs and its role in pulmonary hypertension. J Clin Invest 2008; 118:1846\u20131857.","journal-title":"J Clin Invest"},{"key":"BFcr2008326_CR71","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/(SICI)1097-4652(200007)184:1<37::AID-JCP4>3.0.CO;2-M","volume":"184","author":"H Dorai","year":"2000","unstructured":"Dorai H, Vukicevic S, Sampath TK . Bone morphogenetic protein-7 (osteogenic protein-1) inhibits smooth muscle cell proliferation and stimulates the expression of markers that are characteristic of SMC phenotype in vitro. J Cell Physiol 2000; 184:37\u201345.","journal-title":"J Cell Physiol"},{"key":"BFcr2008326_CR72","doi-asserted-by":"publisher","first-page":"L1059","DOI":"10.1152\/ajplung.00180.2006","volume":"291","author":"G Lagna","year":"2006","unstructured":"Lagna G, Nguyen PH, Ni W, Hata A . BMP-dependent activation of caspase-9 and caspase-8 mediates apoptosis in pulmonary artery smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 2006; 291:L1059\u20131067","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"BFcr2008326_CR73","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/nature07086","volume":"454","author":"BN Davis","year":"2008","unstructured":"Davis BN, Hilyard AC, Lagna G, Hata A . SMAD proteins control DROSHA-mediated microRNA maturation. Nature 2008; 454:56\u201361.","journal-title":"Nature"},{"key":"BFcr2008326_CR74","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1006\/dbio.1996.0225","volume":"178","author":"JE Hungerford","year":"1996","unstructured":"Hungerford JE, Owens GK, Argraves WS, Little CD . Development of the aortic vessel wall as defined by vascular smooth muscle and extracellular matrix markers. Dev Biol 1996; 178:375\u2013392.","journal-title":"Dev Biol"},{"key":"BFcr2008326_CR75","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1089\/scd.2004.13.509","volume":"13","author":"R Ding","year":"2004","unstructured":"Ding R, Darland DC, Parmacek MS, D'Amore PA . Endothelial-mesenchymal interactions in vitro reveal molecular mechanisms of smooth muscle\/pericyte differentiation. Stem Cells Dev 2004; 13:509\u2013520.","journal-title":"Stem Cells Dev"},{"key":"BFcr2008326_CR76","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1006\/dbio.1999.9534","volume":"217","author":"HM Arthur","year":"2000","unstructured":"Arthur HM, Ure J, Smith AJ, et al. Endoglin, an ancillary TGF\u03b2 receptor, is required for extraembryonic angiogenesis and plays a key role in heart development. Dev Biol 2000; 217: 42\u201353.","journal-title":"Dev Biol"},{"key":"BFcr2008326_CR77","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1002\/jcb.1179","volume":"82","author":"T Yamamoto","year":"2001","unstructured":"Yamamoto T, Kozawa O, Tanabe K, et al. Involvement of p38 MAP kinase in TGF-\u03b2-stimulated VEGF synthesis in aortic smooth muscle cells. J Cell Biochem 2001; 82:591\u2013598.","journal-title":"J Cell Biochem"},{"key":"BFcr2008326_CR78","first-page":"5053","volume":"7","author":"SM Black","year":"2004","unstructured":"Black SM, Grobe A, Mata-Greenwood E, Noskina Y . Cyclic stretch increases VEGF expression in pulmonary arterial smooth muscle cells via TGF-\u03b21 and reactive oxygen species: a requirement for NAD(P)H oxidase. Conf Proc IEEE Eng Med Biol Soc 2004; 7:5053\u20135056.","journal-title":"Conf Proc IEEE Eng Med Biol Soc"},{"key":"BFcr2008326_CR79","doi-asserted-by":"publisher","unstructured":"Dongmei L, Cuili Z, Song F, Lubenec I, Tian Y, Song QH . VEGF regulates FGF-2 and TGF-\u03b21 expression in injury endothelial cells and mediates smooth muscle cells proliferation and migration. Microvasc Res 2008 Oct 2. doi: 10.1016\/j.mvr.2008.09.007 .","DOI":"10.1016\/j.mvr.2008.09.007"},{"key":"BFcr2008326_CR80","doi-asserted-by":"publisher","first-page":"3317","DOI":"10.1242\/jcs.028282","volume":"121","author":"T Kokudo","year":"2008","unstructured":"Kokudo T, Suzuki Y, Yoshimatsu Y, Yamazaki T, Watabe T, Miyazono K . Snail is required for TGF\u03b2-induced endothelial-mesenchymal transition of embryonic stem cell-derived endothelial cells. J Cell Sci 2008; 121:3317\u20133324.","journal-title":"J Cell Sci"},{"key":"BFcr2008326_CR81","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1136\/jmg.2005.030833","volume":"43","author":"SA Abdalla","year":"2006","unstructured":"Abdalla SA, Letarte M . Hereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of disease. J Med Genet 2006; 43:97\u2013110.","journal-title":"J Med Genet"},{"key":"BFcr2008326_CR82","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/ng1294-345","volume":"8","author":"KA McAllister","year":"1994","unstructured":"McAllister KA, Grogg KM, Johnson DW, et al. Endoglin, a TGF-\u03b2 binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat Genet 1994; 8:345\u2013351.","journal-title":"Nat Genet"},{"key":"BFcr2008326_CR83","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/ng0696-189","volume":"13","author":"DW Johnson","year":"1996","unstructured":"Johnson DW, Berg JN, Baldwin MA, et al. Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nat Genet 1996; 13:189\u2013195.","journal-title":"Nat Genet"},{"key":"BFcr2008326_CR84","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1136\/jmg.2006.041517","volume":"43","author":"CJ Gallione","year":"2006","unstructured":"Gallione CJ, Richards JA, Letteboer TG, et al. SMAD4 mutations found in unselected HHT patients. J Med Genet 2006; 43:793\u2013797.","journal-title":"J Med Genet"},{"key":"BFcr2008326_CR85","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1182\/blood-2007-08-107359","volume":"111","author":"SO Park","year":"2008","unstructured":"Park SO, Lee YJ, Seki T, et al. ALK5- and TGFBR2-independent role of ALK1 in the pathogenesis of hereditary hemorrhagic telangiectasia type 2. Blood 2008; 111:633\u2013642.","journal-title":"Blood"},{"key":"BFcr2008326_CR86","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1016\/S0002-9440(10)64673-1","volume":"158","author":"A Bourdeau","year":"2001","unstructured":"Bourdeau A, Faughnan ME, McDonald ML, Paterson AD, Wanless IR, Letarte M . Potential role of modifier genes influencing transforming growth factor-\u03b21 levels in the development of vascular defects in endoglin heterozygous mice with hereditary hemorrhagic telangiectasia. Am J Pathol 2001; 158:2011\u20132020.","journal-title":"Am J Pathol"},{"key":"BFcr2008326_CR87","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1136\/jmg.2005.039669","volume":"43","author":"PN Robinson","year":"2006","unstructured":"Robinson PN, Arteaga-Solis E, Baldock C, et al. The molecular genetics of Marfan syndrome and related disorders. J Med Genet 2006; 43:769\u2013787.","journal-title":"J Med Genet"},{"key":"BFcr2008326_CR88","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/ng1116","volume":"33","author":"ER Neptune","year":"2003","unstructured":"Neptune ER, Frischmeyer PA, Arking DE, et al. Dysregulation of TGF-\u03b2 activation contributes to pathogenesis in Marfan syndrome. Nat Genet 2003; 33:407\u2013411.","journal-title":"Nat Genet"},{"key":"BFcr2008326_CR89","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/nm1536","volume":"13","author":"RD Cohn","year":"2007","unstructured":"Cohn RD, van Erp C, Habashi JP, et al. Angiotensin II type 1 receptor blockade attenuates TGF-\u03b2-induced failure of muscle regeneration in multiple myopathic states. Nat Med 2007; 13:204\u2013210.","journal-title":"Nat Med"},{"key":"BFcr2008326_CR90","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1126\/science.1124287","volume":"312","author":"JP Habashi","year":"2006","unstructured":"Habashi JP, Judge DP, Holm TM, et al. Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science 2006; 312:117\u2013121.","journal-title":"Science"},{"key":"BFcr2008326_CR91","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1056\/NEJMoa055695","volume":"355","author":"BL Loeys","year":"2006","unstructured":"Loeys BL, Schwarze U, Holm T, et al. Aneurysm syndromes caused by mutations in the TGF-\u03b2 receptor. N Engl J Med 2006; 355:788\u2013798.","journal-title":"N Engl J Med"},{"key":"BFcr2008326_CR92","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/ng1511","volume":"37","author":"BL Loeys","year":"2003","unstructured":"Loeys BL, Chen J, Neptune ER, et al. A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nat Genet 2003; 37:275\u2013281.","journal-title":"Nat Genet"},{"key":"BFcr2008326_CR93","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.1056\/NEJMoa0706585","volume":"358","author":"BS Brooke","year":"2008","unstructured":"Brooke BS, Habashi JP, Judge DP, Patel N, Loeys B, Dietz HC . Angiotensin II blockade and aortic-root dilation in Marfan's syndrome. N Engl J Med 2008; 358:2787\u20132795.","journal-title":"N Engl J Med"},{"key":"BFcr2008326_CR94","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1053\/j.semperi.2006.01.008","volume":"30","author":"BM Sibai","year":"2006","unstructured":"Sibai BM . Preeclampsia as a cause of preterm and late preterm (near-term) births. Semin Perinatol 2006; 30:16\u201319.","journal-title":"Semin Perinatol"},{"key":"BFcr2008326_CR95","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1056\/NEJMoa055352","volume":"355","author":"RJ Levine","year":"2006","unstructured":"Levine RJ, Lam C, Qian C, et al. CPEP Study Group. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 2006; 355:992\u20131005.","journal-title":"N Engl J Med"},{"key":"BFcr2008326_CR96","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/nm1429","volume":"12","author":"S Venkatesha","year":"2006","unstructured":"Venkatesha S, Toporsian M, Lam C, et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 2006; 12:642\u2013649.","journal-title":"Nat Med"},{"key":"BFcr2008326_CR97","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1161\/01.CIR.0000012754.72951.3D","volume":"105","author":"C Atkinson","year":"2002","unstructured":"Atkinson C, Stewart S, Upton PD, et al. Primary pulmonary hypertension is associated with reduced pulmonary vascular expression of type II bone morphogenetic protein receptor. Circulation 2002; 105:1672\u20131678.","journal-title":"Circulation"},{"key":"BFcr2008326_CR98","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/S0002-9440(10)65137-1","volume":"155","author":"CD Cool","year":"1999","unstructured":"Cool CD, Stewart JS, Werahera P, et al. Three-dimensional reconstruction of pulmonary arteries in plexiform pulmonary hypertension using cell-specific markers. Evidence for a dynamic and heterogeneous process of pulmonary endothelial cell growth. Am J Pathol 1999; 155:411\u2013419.","journal-title":"Am J Pathol"},{"key":"BFcr2008326_CR99","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/79226","volume":"26","author":"KB Lane","year":"2000","unstructured":"Lane KB, Machado RD, Pauciulo MW, et al. Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension. The International PPH Consortium. Nat Genet 2000; 26:81\u201384.","journal-title":"Nat Genet"},{"key":"BFcr2008326_CR100","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/humu.20285","volume":"27","author":"RD Machado","year":"2006","unstructured":"Machado RD, Aldred MA, James V, et al. Mutations of the TGF-\u03b2 type II receptor BMPR2 in pulmonary arterial hypertension. Hum Mutat 2006; 27:121\u2013132.","journal-title":"Hum Mutat"},{"key":"BFcr2008326_CR101","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1253\/circj.72.127","volume":"72","author":"M Fujiwara","year":"2008","unstructured":"Fujiwara M, Yagi H, Matsuoka R, et al. Implications of mutations of activin receptor-like kinase 1 gene (ALK1) in addition to bone morphogenetic protein receptor II gene (BMPR2) in children with pulmonary arterial hypertension. Circ J 2008; 72:127\u2013133.","journal-title":"Circ J"},{"key":"BFcr2008326_CR102","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1161\/01.RES.0000126047.82846.20","volume":"94","author":"J West","year":"2004","unstructured":"West J, Fagan K, Steudel W, et al. Pulmonary hypertension in transgenic mice expressing a dominant-negative BMPRII gene in smooth muscle. Circ Res 2004; 94:1109\u20131114.","journal-title":"Circ Res"},{"key":"BFcr2008326_CR103","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1161\/CIRCRESAHA.108.173567","volume":"102","author":"J Yang","year":"2008","unstructured":"Yang J, Davies RJ, Southwood M, et al. Mutations in bone morphogenetic protein type II receptor cause dysregulation of Id gene expression in pulmonary artery smooth muscle cells: implications for familial pulmonary arterial hypertension. Circ Res 2008; 102:1212\u20131221.","journal-title":"Circ Res"},{"key":"BFcr2008326_CR104","doi-asserted-by":"publisher","first-page":"3877","DOI":"10.1074\/jbc.M706797200","volume":"283","author":"PB Yu","year":"2008","unstructured":"Yu PB, Deng DY, Beppu H, et al. Bone morphogenetic protein (BMP) type II receptor is required for BMP-mediated growth arrest and differentiation in pulmonary artery smooth muscle cells. J Biol Chem 2008; 283:3877\u20133888.","journal-title":"J Biol Chem"},{"key":"BFcr2008326_CR105","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1378\/chest.06-2674","volume":"131","author":"DB Badesch","year":"2007","unstructured":"Badesch DB, Abman SH, Simonneau G, Rubin LJ, McLaughlin VV . Medical therapy for pulmonary arterial hypertension: updated ACCP evidence-based clinical practice guidelines. Chest 2007; 131:1917\u20131928.","journal-title":"Chest"},{"key":"BFcr2008326_CR106","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1161\/CIRCULATIONAHA.107.704197","volume":"116","author":"M Bujak","year":"2007","unstructured":"Bujak M, Ren G, Kweon HJ, et al. Essential role of Smad3 in infarct healing and in the pathogenesis of cardiac remodeling. Circulation 2007; 116:2127\u20132138.","journal-title":"Circulation"},{"key":"BFcr2008326_CR107","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.cardiores.2004.04.030","volume":"63","author":"S Rosenkranz","year":"2004","unstructured":"Rosenkranz S . TGF-\u03b21 and angiotensin networking in cardiac remodeling. Cardiovasc Res 2004; 63:423\u2013432.","journal-title":"Cardiovasc Res"},{"key":"BFcr2008326_CR108","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/0092-8674(93)90541-W","volume":"75","author":"J Sadoshima","year":"1993","unstructured":"Sadoshima J, Xu Y, Slayter HS, Izumo S . Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell 1993; 75:977\u2013984.","journal-title":"Cell"},{"key":"BFcr2008326_CR109","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.bbrc.2005.11.060","volume":"339","author":"Y Zhou","year":"2006","unstructured":"Zhou Y, Poczatek MH, Berecek KH, Murphy-Ullrich JE . Thrombospondin 1 mediates angiotensin II induction of TGF-\u03b2 activation by cardiac and renal cells under both high and low glucose conditions. Biochem Biophys Res Commun 2006; 339:633\u2013641.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFcr2008326_CR110","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1161\/01.RES.0000218782.52610.dc","volume":"98","author":"W Wang","year":"2006","unstructured":"Wang W, Huang XR, Canlas E, et al. Essential role of Smad3 in angiotensin II-induced vascular fibrosis. Circ Res 2006; 98:1032\u20131039.","journal-title":"Circ Res"},{"key":"BFcr2008326_CR111","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1146\/annurev.ph.57.030195.004105","volume":"57","author":"JM Pfeffer","year":"1995","unstructured":"Pfeffer JM, Fischer TA, Pfeffer MA . Angiotensin-converting enzyme inhibition and ventricular remodeling after myocardial infarction. Annu Rev Physiol 1995; 57:805\u2013826.","journal-title":"Annu Rev Physiol"},{"key":"BFcr2008326_CR112","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1517\/14656566.5.11.2311","volume":"5","author":"RB Devereux","year":"2004","unstructured":"Devereux RB, Lyle PA . Losartan for the treatment of hypertension and left ventricular hypertrophy: the Losartan intervention for endpoint reduction in hypertension (LIFE) study. Expert Opin Pharmacother 2004; 5:2311\u20132320.","journal-title":"Expert Opin Pharmacother"},{"key":"BFcr2008326_CR113","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1172\/JCI114466","volume":"85","author":"TG Parker","year":"1990","unstructured":"Parker TG, Packer SE, Schneider MD . Peptide growth factors can provoke \u201cfetal\u201d contractile protein gene expression in rat cardiac myocytes. J Clin Invest 1990; 85:507\u2013514.","journal-title":"J Clin Invest"},{"key":"BFcr2008326_CR114","doi-asserted-by":"publisher","first-page":"H1253","DOI":"10.1152\/ajpheart.00578.2001","volume":"283","author":"S Rosenkranz","year":"2002","unstructured":"Rosenkranz S, Flesch M, Amann K, et al. Alterations of \u03b2-adrenergic signaling and cardiac hypertrophy in transgenic mice overexpressing TGF-\u03b21. Am J Physiol Heart Circ Physiol 2002; 283:H1253\u20131262.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"BFcr2008326_CR115","unstructured":"Goumans MJ, Zonneveld AJ, ten Dijke P . TGF\u03b2-induced endothelial to mesenchymal transition; a switch to cardiac fibrosis? Trends Cardiovasc Med, in press."},{"key":"BFcr2008326_CR116","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1093\/emboj\/20.7.1663","volume":"20","author":"J Larsson","year":"2001","unstructured":"Larsson J, Goumans MJ, Sj\u00f6strand LJ, et al. Abnormal angiogenesis but intact hematopoietic potential in TGF-\u03b2 type I receptor-deficient mice. EMBO J 2001; 20:1663\u20131673.","journal-title":"EMBO J"},{"key":"BFcr2008326_CR117","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1056\/NEJM199510053331407","volume":"333","author":"AE Guttmacher","year":"1995","unstructured":"Guttmacher AE, Marchuk DA, White RI Jr. Hereditary hemorrhagic telangiectasia. N Engl J Med 1995; 333:918\u2013924.","journal-title":"N Engl J Med"}],"container-title":["Cell Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/cr2008326.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/cr2008326","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/cr2008326.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T03:59:45Z","timestamp":1684814385000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cr2008326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12,30]]},"references-count":117,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["BFcr2008326"],"URL":"https:\/\/doi.org\/10.1038\/cr.2008.326","relation":{},"ISSN":["1001-0602","1748-7838"],"issn-type":[{"value":"1001-0602","type":"print"},{"value":"1748-7838","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,12,30]]}}}